A new meta-analysis published in Scientific Reports has found that the protein opiorphin may be a valuable biomarker for orofacial conditions, such as chronic pain and oral diseases. The study found that salivary opiorphin levels were elevated in people with orofacial conditions compared to those without. This suggests that opiorphin could help diagnose and monitor orofacial conditions and develop new treatments.
Related Posts
A New Era in Surgical Pathology Education: The Implementation of Entrustable Professional Activities (EPAs)
Introduction: In the ever-evolving field of medicine, competency-based medical education (CBME) has emerged as a transformative approach to training future physicians. This innovative methodology emphasizes the development of entrustable professional activities (EPAs), specific skills and competencies that trainees must master to become independent and confident practitioners. Background: Entrustable professional activities (EPAs) have been successfully implemented […]
Researchers develop ultra-sensitive photoacoustic microscopy for biomedical uses
Researchers from City University of Hong Kong have created a ground-breaking super-low-dose photoacoustic microscopy(SLD-PAM) system that increases sensitivity by 33 times and completely transforms photoacoustic microscopy. This non-invasive imaging development offers a wide range of biological applications, less photobleaching, lower prices, and the possibility of portable microscopy, which will advance clinical use.
New study finds link between gum inflammation and cytokine levels in saliva.
Researchers at NYU College of Dentistry have developed a single score to describe the level of cytokines in the saliva, and this score is linked with the severity of clinical gum inflammation. The study, could lead to new ways to diagnose and treat gum disease.